The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ...

And GSK announced Thursday that the FDA had approved its medication gepotidacin, with the brand name Blujepa, as oral tablets ...

California health officials say 63 people have fallen ill with Salmonella Enteritidis infections tied to eggs. Thirteen of ...

Over the past few weeks, the province's Ministry of Agriculture, Fisheries and Food (MAPAQ) and the Canadian Food Inspection ...

Vincenzo's brand Sweet and Savory Mix is under recall in Canada because of contamination with Salmonella. The product was ...

Overall, tucatinib add-on to first-line maintenance therapy for HER2-positive metastatic breast cancer delayed progression by ...

Immunome’s investigational oral therapy has slashed the risk of disease progression or death by 84% for patients with desmoid ...

The addition of tucatinib to first-line trastuzumab plus pertuzumab delayed disease progression among a cohort of women with ...

In the analyses, 68% percent of patients received prior CHOP-based therapy, 35% had salvage chemotherapy, 20% had autologous stem cell transplant, 17% had an HDAC inhibitor, and 38% had prior exposure ...

It's easy to feel lost in the vast wilderness that is stomach-or more accurately, abdominal-pain. But doctors have learned to ...

“Olomorasib, in combination with pembrolizumab, has demonstrated significant efficacy and a manageable safety profile in patients with KRAS G12C-mutant advanced/metastatic NSCLC, including patients ...

Presentation Title: The ADELA study: A Double-blind, Placebo-controlled, Randomized Phase 3 Trial of Elacestrant (ELA)+ Everolimus (EVE) Versus ELA + Placebo (PBO) in ER+/HER2-Advanced Breast Cancer ...